相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Combination Therapy of an Inhibitor of Group VIA Phospholipase A2 with Paclitaxel Is Highly Effective in Blocking Ovarian Cancer Development
Hui Li et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
EGF and angiotensin II modulate lysophosphatidic acid LPA1 receptor function and phosphorylation state
Christian C. Colin-Santana et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2011)
Regulation of lysophosphatidate signaling by autotaxin and lipid phosphate phosphatases with respect to tumor progression, angiogenesis, metastasis and chemo-resistance
Nasser Samadi et al.
BIOCHIMIE (2011)
Autotaxin and LPA receptor signaling in cancer
Anna J. S. Houben et al.
CANCER AND METASTASIS REVIEWS (2011)
Secreted phospholipase A2 revisited
Makoto Murakami et al.
JOURNAL OF BIOCHEMISTRY (2011)
Epidermal growth factor increases lysophosphatidic acid production in human ovarian cancer cells: roles for phospholipase D-2 and receptor transactivation
Ashley J. Snider et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2010)
Emerging roles for phospholipase A(2) enzymes in cancer
Kieran F. Scott et al.
BIOCHIMIE (2010)
Activation of Phosphatidylcholine Cycle Enzymes in Human Epithelial Ovarian Cancer Cells
Egidio Iorio et al.
CANCER RESEARCH (2010)
Group VIA phospholipase A2 in both host and tumor cells is involved in ovarian cancer development
Hui Li et al.
FASEB JOURNAL (2010)
An extremely simple method for extraction of lysophospholipids and phospholipids from blood samples
Zhenwen Zhao et al.
JOURNAL OF LIPID RESEARCH (2010)
Exosomes account for vesicle-mediated transcellular transport of activatable phospholipases and prostaglandins
Caroline Subra et al.
JOURNAL OF LIPID RESEARCH (2010)
Hsp60 Is Actively Secreted by Human Tumor Cells
Anna M. Merendino et al.
PLOS ONE (2010)
Phospholipase A2 Biochemistry
John E. Burke et al.
CARDIOVASCULAR DRUGS AND THERAPY (2009)
Characterization of the ATP-dependent Sphingosine 1-Phosphate Transporter in Rat Erythrocytes
Naoki Kobayashi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Measurement of endogenous lysophosphatidic acid by ESI-MS/MS in plasma samples requires pre-separation of lysophosphatidylcholine
Zhenwen Zhao et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2009)
Phospholipase A2 structure/function, mechanism, and signaling
John E. Burke et al.
JOURNAL OF LIPID RESEARCH (2009)
Lysophosphatidic acid stimulates cell migration, invasion, and colony formation as well as tumorigenesis/metastasis of mouse ovarian cancer in immunocompetent mice
Hui Li et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Lysophosphatidic Acid-Induced Transcriptional Profile Represents Serous Epithelial Ovarian Carcinoma and Worsened Prognosis
Mandi M. Murph et al.
PLOS ONE (2009)
Two pathways for lysophosphatidic acid production
Junken Aoki et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2008)
Role of LPA4/p2y9/GPR23 in Negative Regulation of Cell Motility
Zendra Lee et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
Phospholipase A2 as targets for anti-cancer drugs
Brian S. Cummings
BIOCHEMICAL PHARMACOLOGY (2007)
Inhibition of calcium-independent phospholipase A2 suppresses proliferation and tumorigenicity of ovarian carcinoma cells
Yuanda Song et al.
BIOCHEMICAL JOURNAL (2007)
Lysophosphatidic acid downregulates tissue inhibitor of metalloproteinases, which are negatively involved in lysophosphatidic acid-induced cell invasion
S. Sengupta et al.
ONCOGENE (2007)
A comparative proteomic study to characterize the vinblastine resistance in human ovarian cancer cells
Dawn P. G. Brown et al.
PROTEOMICS CLINICAL APPLICATIONS (2007)
Caspase-3-dependent activation of calcium-independent phospholipase A2 enhances cell migration in non-apoptotic ovarian cancer cells
Xiaoxian Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Hypoxia enhances lysophosphatidic acid responsiveness in ovarian cancer cells and lysophosphatidic acid induces ovarian tumor metastasis in vivo
Kwan-Sik Kim et al.
CANCER RESEARCH (2006)
Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells
J Ren et al.
CANCER RESEARCH (2006)
Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function
CR Liu et al.
JOURNAL OF IMMUNOLOGY (2006)
Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas
ND Hendrix et al.
CANCER RESEARCH (2006)
Distinguishing phospholipase A2 types in biological samples by employing group-specific assays in the presence of inhibitors
KK Lucas et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2005)
The emerging role of lysophosphatidic acid in cancer
GB Mills et al.
NATURE REVIEWS CANCER (2003)
A novel laminin-induced lysophosphatidic acid autocrine loop in the migration of ovarian
S Sengupta et al.
FASEB JOURNAL (2003)
Phospholipase A2 enzymes
I Kudo et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2002)
Electrospray ionization mass spectrometry analysis of lysophospholipids in human ascitic fluids: Comparison of the lysophospholipid contents in malignant vs nonmalignant ascitic fluids
YJ Xiao et al.
ANALYTICAL BIOCHEMISTRY (2001)
Gelsolin finding and cellular presentation of lysophosphatidic acid
EJ Goetzl et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
